CoChat
Sign Up
Cited by 54

Epigenetic Silencing of miR-338-3p Contributes to Tumorigenicity in Gastric Cancer by Targeting SSX2IP

Li, Pu, Chen, Xuehua, Su, Liping, Li, Chenglong, Zhi, Qiaoming, Yu, Beiqin, Sheng, Hong, Wang, Junqing +7 more·2013·PLoS ONE
DOI 10.1371/journal.pone.0066782PMC PMC3691322
Open this paper in CoChat — free account

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0066782

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

No references could be resolved yet.

Research works printed but not linked: 43

  1. [1]Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2002. CA Cancer J Clin 55: 74– 108. 15761078
  2. [2]O’Hara SP, Mott JL, Splinter PL, Gores GJ, LaRusso NF (2009) MicroRNAs: key modulators of posttranscriptional gene expression. Gastroenterology 136: 17– 25. 19049808 PMC3156441
  3. [3]Brueckner B, Stresemann C, Kuner R, Mund C, Musch T, et al (2007) The human let-7a-3 locus contains an epigenetically regulated microRNA gene with oncogenic function. Cancer Res 67: 1419– 1423. 17308078
  4. [4]Gupta GP, Massague J (2006) Cancer metastasis: building a framework. Cell 127: 679– 695. 17110329
  5. [5]Calin GA, Sevignani C, Dumitru CD, Hyslop T, Noch E, et al (2004) Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci U S A 101: 2999– 3004. 14973191 PMC365734
  6. [6]Schoof CR, Botelho EL, Izzotti A, Vasques Ldos R (2012) MicroRNAs in cancer treatment and prognosis. Am J Cancer Res 2: 414– 433. 22860232 PMC3410578
  7. [7]Zhang B, Pan X, Cobb GP, Anderson TA (2007) microRNAs as oncogenes and tumor suppressors. Dev Biol 302: 1– 12. 16989803
  8. [8]Song JH, Meltzer SJ (2012) MicroRNAs in pathogenesis, diagnosis, and treatment of gastroesophageal cancers. Gastroenterology 143: 35–47 e32. 22580099
  9. [9]Johnson SM, Grosshans H, Shingara J, Byrom M, Jarvis R, et al (2005) RAS is regulated by the let-7 microRNA family. Cell 120: 635– 647. 15766527
  10. [10]Zhang HH, Wang XJ, Li GX, Yang E, Yang NM (2007) Detection of let-7a microRNA by real-time PCR in gastric carcinoma. World J Gastroenterol 13: 2883– 2888. 17569129 PMC4395645
  11. [11]Chan SH, Wu CW, Li AF, Chi CW, Lin WC (2008) miR-21 microRNA expression in human gastric carcinomas and its clinical association. Anticancer Res 28: 907– 911. 18507035
  12. [12]Xia L, Zhang D, Du R, Pan Y, Zhao L, et al (2008) miR-15b and miR-16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells. Int J Cancer 123: 372– 379. 18449891
  13. [13]Feng R, Chen X, Yu Y, Su L, Yu B, et al (2010) miR-126 functions as a tumour suppressor in human gastric cancer. Cancer Lett 298: 50– 63. 20619534
  14. [14]Li C, Nie H, Wang M, Su L, Li J, et al (2012) MicroRNA-409–3p regulates cell proliferation and apoptosis by targeting PHF10 in gastric cancer. Cancer Lett 320: 189– 197. 22388101
  15. [15]Li CL, Nie H, Wang M, Su LP, Li JF, et al (2012) microRNA-155 is downregulated in gastric cancer cells and involved in cell metastasis. Oncol Rep 27: 1960– 1966. 22426647
  16. [16]Saba R, Goodman CD, Huzarewich RL, Robertson C, Booth SA (2008) A miRNA signature of prion induced neurodegeneration. PLoS One 3: e3652. 18987751 PMC2575400
  17. [17]Kos A, Olde Loohuis NF, Wieczorek ML, Glennon JC, Martens GJ, et al (2012) A potential regulatory role for intronic microRNA-338–3p for its host gene encoding apoptosis-associated tyrosine kinase. PLoS One 7: e31022. 22363537 PMC3281898
  18. [18]De Felice B, Guida M, Coppola C, De Mieri G, Cotrufo R (2012) A miRNA signature in leukocytes from sporadic amyotrophic lateral sclerosis. Gene 508: 35– 40. 22903028
  19. [19]Gaedcke J, Grade M, Camps J, Sokilde R, Kaczkowski B, et al (2012) The Rectal Cancer microRNAome - microRNA Expression in Rectal Cancer and Matched Normal Mucosa. Clin Cancer Res 18: 4919– 4930. 22850566 PMC6298229
  20. [20]Fu X, Tan D, Hou Z, Hu Z, Liu G (2012) miR-338–3p Is Down-Regulated by Hepatitis B Virus X and Inhibits Cell Proliferation by Targeting the 3′-UTR Region of CyclinD1. Int J Mol Sci 13: 8514– 8539. 22942717 PMC3430248
  21. [21]Fu X, Tan D, Hou Z, Hu Z, Liu G, et al (2012) The Effect of miR-338–3p on HBx Deletion-Mutant (HBx-d382) Mediated Liver-Cell Proliferation through CyclinD1 Regulation. PLoS One 7: e43204. 22912826 PMC3422285
  22. [22]Huang XH, Chen JS, Wang Q, Chen XL, Wen L, et al (2011) miR-338–3p suppresses invasion of liver cancer cell by targeting smoothened. J Pathol 225: 463– 472. 21671467
  23. [23]Lin CH, Fu ZM, Liu YL, Yang JL, Xu JF, et al (1984) Investigation of SGC-7901 cell line established from human gastric carcinoma cells. Chin Med J (Engl) 97: 831– 834. 6443274
  24. [24]Park JG, Frucht H, LaRocca RV, Bliss DP Jr, Kurita Y, et al (1990) Characteristics of cell lines established from human gastric carcinoma. Cancer Res 50: 2773– 2780. 2158397
  25. [25]Lu YY, Lu GR, Xu XL, Ee Z, Miao J, et al (1986) [DNA transformation activity of a human gastrocarcinoma cell line]. Zhonghua Zhong Liu Za Zhi 8: 241– 244. 3757734
  26. [26]Barranco SC, Townsend CM Jr, Casartelli C, Macik BG, Burger NL, et al (1983) Establishment and characterization of an in vitro model system for human adenocarcinoma of the stomach. Cancer Res 43: 1703– 1709. 6831414
  27. [27]Sekiguchi M, Sakakibara K, Fujii G (1978) Establishment of cultured cell lines derived from a human gastric carcinoma. Jpn J Exp Med 48: 61– 68. 209229
  28. [28]Motoyama T, Hojo H, Watanabe H (1986) Comparison of seven cell lines derived from human gastric carcinomas. Acta Pathol Jpn 36: 65– 83. 3962675
  29. [29]Ke Y, Ning T, Wang B (1994) [Establishment and characterization of a SV40 transformed human fetal gastric epithelial cell line-GES-1]. Zhonghua Zhong Liu Za Zhi 16: 7– 10. 8033753
  30. [30]Chen J, Wang W, Zhang T, Ji J, Qian Q, et al (2012) Differential expression of phospholipase C epsilon 1 is associated with chronic atrophic gastritis and gastric cancer. PLoS One 7: e47563. 23077637 PMC3471869
  31. [31]Fabbri M, Calore F, Paone A, Galli R, Calin GA (2013) Epigenetic Regulation of miRNAs in Cancer. Adv Exp Med Biol 754: 137– 148. 22956499
  32. [32]Bandres E, Agirre X, Bitarte N, Ramirez N, Zarate R, et al (2009) Epigenetic regulation of microRNA expression in colorectal cancer. Int J Cancer 125: 2737– 2743. 19521961
  33. [33]Guinn BA, Bullinger L, Thomas NS, Mills KI, Greiner J (2008) SSX2IP expression in acute myeloid leukaemia: an association with mitotic spindle failure in t(8;21), and cell cycle in t(15;17) patients. Br J Haematol 140: 250– 251. 18028484
  34. [34]Guinn B, Greiner J, Schmitt M, Mills KI (2009) Elevated expression of the leukemia-associated antigen SSX2IP predicts survival in acute myeloid leukemia patients who lack detectable cytogenetic rearrangements. Blood 113: 1203– 1204. 19179477
  35. [35]Zhang L, Greiner J (2011) Leukemia-associated antigens are immunogenic and have prognostic value in acute myeloid leukemia. Immunotherapy 3: 697– 699. 21668302
  36. [36]Li P, Lin Y, Zhang Y, Zhu Z, Huo K (2013) SSX2IP promotes metastasis and chemotherapeutic resistance of hepatocellular carcinoma. J Transl Med 11: 52. 23452395 PMC3599991
  37. [37]Saxonov S, Berg P, Brutlag DL (2006) A genome-wide analysis of CpG dinucleotides in the human genome distinguishes two distinct classes of promoters. Proc Natl Acad Sci U S A 103: 1412– 1417. 16432200 PMC1345710
  38. [38]Tsai KW, Wu CW, Hu LY, Li SC, Liao YL, et al (2011) Epigenetic regulation of miR-34b and miR-129 expression in gastric cancer. Int J Cancer 129: 2600– 2610. 21960261
  39. [39]Kim K, Lee HC, Park JL, Kim M, Kim SY, et al (2011) Epigenetic regulation of microRNA-10b and targeting of oncogenic MAPRE1 in gastric cancer. Epigenetics 6: 740– 751. 21562367
  40. [40]Hayashi Y, Tsujii M, Wang J, Kondo J, Akasaka T, et al.. (2012) CagA mediates epigenetic regulation to attenuate let-7 expression in Helicobacter pylori-related carcinogenesis. Gut. 22936674
  41. [41]Asada M, Irie K, Morimoto K, Yamada A, Ikeda W, et al (2003) ADIP, a novel Afadin- and alpha-actinin-binding protein localized at cell-cell adherens junctions. J Biol Chem 278: 4103– 4111. 12446711
  42. [42]Fukumoto Y, Kurita S, Takai Y, Ogita H (2011) Role of scaffold protein afadin dilute domain-interacting protein (ADIP) in platelet-derived growth factor-induced cell movement by activating Rac protein through Vav2 protein. J Biol Chem 286: 43537– 43548. 22027834 PMC3234878
  43. [43]Pan Y, Bi F, Liu N, Xue Y, Yao X, et al (2004) Expression of seven main Rho family members in gastric carcinoma. Biochem Biophys Res Commun 315: 686– 691. 14975755

Cited by

Sorted by citations

Authors
Li, P., Chen, X., Su, L., Li, C., Zhi, Q., Yu, B., Sheng, H., Wang, J., Feng, R., Cai, Q., Li, J., Yu, Y., Yan, M., Liu, B., & Zhu, Z.
Venue
PLoS ONE
Publisher
Public Library of Science (PLoS)
Published
2013-06-24
Volume
8
Issue
6
Pages
e66782
ISSN
1932-6203
DOI
10.1371/journal.pone.0066782
PMC
PMC3691322
Cited by
54
References
0
Language
en
Licence
creativecommons.org/licenses/by/4.0/ (unspecified)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review